We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

80 hedge funds and large institutions have $103M invested in ARK Genomic Revolution ETF in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 5

76% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 17

11% more funds holding

Funds holding: 72 → 80 (+8)

2.56% more ownership

Funds ownership: 22.91% → 25.46% (+2.6%)

2% less capital invested

Capital invested by funds: $105M → $103M (-$1.95M)

Holders
80
Holders Change
+8
Holders Change %
+11.11%
% of All Funds
1.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
13
Increased
30
Reduced
17
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RJA
Raymond James & Associates
Florida
+$4.05M
2
CAN
Claraphi Advisory Network
United States
+$2.56M
3
TRCT
Tower Research Capital (TRC)
New York
+$2.51M
4
Morgan Stanley
Morgan Stanley
New York
+$1.73M
5
HT
HAP Trading
New York
+$1.51M

Top Sellers

Rank Fund Capital Flow
1
SI
Stephens Inc
Arkansas
-$3.22M
2
UBS Group
UBS Group
Switzerland
-$537K
3
MIAN
Mariner Independent Advisor Network
Kansas
-$293K
4
SWM
SeaCrest Wealth Management
New York
-$291K
5
SCA
Snowden Capital Advisors
New York
-$281K
Name Holding Trade Value Shares
Change 		Change in
Stake
WEC
76
Winslow Evans & Crocker
Massachusetts
$2K – – –
S
77
SignatureFD
Georgia
$2K +$2.02K +62 New
IFAM
78
Institutional & Family Asset Management
Colorado
$1K – – –
JFA
79
JNBA Financial Advisors
Minnesota
$1K – – –
HI
80
Human Investing
Oregon
$1K +$130 +4 +31%
NA
81
NewEdge Advisors
Louisiana
– -$267K -7,743 Closed
PWP
82
Principle Wealth Partners
Connecticut
– -$220K -6,395 Closed
GSWM
83
Golden State Wealth Management
California
– -$15K -450 Closed
GFPC
84
Global Financial Private Capital
Florida
– -$11K -325 Closed
1 2 3
4

ARKG Hedge Fund Activity: Q3 2019 in Review

80 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q3 2019, worth a combined $103M — down 1.9% from $105M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ARKG positions and 5 closed out — a net gain of 8 holders — while 30 added to existing stakes and 17 trimmed.

The largest buyer was Raymond James & Associates, adding an estimated $4.05M. The largest seller was Stephens Inc, cutting an estimated $3.22M.

  • 80 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q3 2019, up from 72 in Q2 2019.
  • Funds reported $103M of ARK Genomic Revolution ETF stock for Q3 2019, down 1.9% quarter-over-quarter.
  • 13 funds opened new ARK Genomic Revolution ETF positions in Q3 2019 and 5 closed out, a net change of +8 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q3 2019 was Raymond James & Associates, an estimated $4.05M added.
  • The largest ARK Genomic Revolution ETF seller in Q3 2019 was Stephens Inc, an estimated $3.22M sold.

Based on aggregated 13F filings for Q3 2019.